The drug will be funded on the NHS to treat ulcerative colitis under certain conditions

The company is participating in LifeArc’s funding initiative for COVID-19 clinical trials

Ilaris works by blocking the effects of IL-1 and suppressing inflammation in patients with this autoinflammatory disorder

Novartis takes aim at Eli Lilly with Cosentyx FDA nod in spondyloarthritis kblankenship Tue, 06/16/2020 – 21:47

Updated Date: Tue, 09 Jun 2020 00:00:00 EDT

Updated Date: Tue, 09 Jun 2020 00:00:00 EDT

Updated Date: Tue, 09 Jun 2020 00:00:00 EDT

Updated Date: Tue, 09 Jun 2020 00:00:00 EDT

Updated Date: Tue, 09 Jun 2020 00:00:00 EDT

U.K. endorses dexamethasone in COVID-19 hours after groundbreaking data release esagonowsky Tue, 06/16/2020 – 15:18